Shukra Pharmaceuticals Ltd - 524632 - Media ReleaseBSE filing · raw filing ↗
13 Aug 2026
⚑ Filing
Shukra Pharmaceuticals Ltd - 524632 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
12 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹24 Cr (−NaN% YoY), PAT ₹13 Cr (−NaN% YoY)BSE filing · raw filing ↗
12 Aug 2026
⚑ Filing
Shukra Pharmaceuticals Ltd - 524632 - Board Meeting Outcome for Quartely Results June 30, 2026BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
